Cytokinetics Historical Income Statement

CYTK
 Stock
  

USD 46.99  2.85  6.46%   

Historical analysis of Cytokinetics income statement accounts such as Interest Expense of 17.7 M, Operating Expenses of 277 M or Preferred Dividends Income Statement Impact of 1.5 M can show how well Cytokinetics performed in making a profits. Evaluating Cytokinetics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cytokinetics's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Cytokinetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cytokinetics is a good buy for the upcoming year.
Continue to Trending Equities.
  
Refresh

Cytokinetics Net Income

(220.98 Million)

About Cytokinetics Income Statement Analysis

Cytokinetics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cytokinetics shareholders. The income statement also shows Cytokinetics investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cytokinetics Income Statement Chart

Cytokinetics Income Statement is one of the three primary financial statements used for reporting Cytokinetics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cytokinetics revenue and expense. Cytokinetics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Cytokinetics Selling General and Administrative Expense is increasing as compared to previous years. The last year's value of Selling General and Administrative Expense was reported at 96.8 Million

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding [TaxExp] and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Cytokinetics financial statement analysis. It represents the amount of money remaining after all of Cytokinetics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Revenues

Revenues refers to the total amount of money received by Cytokinetics for goods sold or services provided during a certain time period. It also includes all of Cytokinetics sales as well as any other increase in Cytokinetics equity.Revenues are reported on Cytokinetics income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.

Selling General and Administrative Expense

A component of Operating Expenses representing the aggregate total costs related to selling a firm's product and services; as well as all other general and administrative expenses. Direct selling expenses (for example; credit; warranty; and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products; for example telephone expenses; Internet; and postal charges. General and administrative expenses include salaries of non-sales personnel; rent; utilities; communication; etc.
Most accounts from Cytokinetics income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cytokinetics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Cytokinetics Selling General and Administrative Expense is increasing as compared to previous years. The last year's value of Selling General and Administrative Expense was reported at 96.8 Million
 2019 2020 2021 2022 (projected)
Revenues USD26.87 M55.83 M70.43 M59.29 M
Revenues26.87 M55.83 M70.43 M59.29 M

Cytokinetics income statement Correlations

Cytokinetics Account Relationship Matchups

Cytokinetics income statement Accounts

201720182019202020212022 (projected)
Consolidated Income(127.79 M)(106.29 M)(121.69 M)(127.29 M)(215.31 M)(220.98 M)
Earning Before Interest and Taxes EBIT(124.77 M)(102.49 M)(115.07 M)(111.33 M)(198.87 M)(204.11 M)
Earning Before Interest and Taxes USD(124.77 M)(102.49 M)(115.07 M)(111.33 M)(198.87 M)(204.11 M)
Gross Profit13.37 M31.5 M26.87 M55.83 M70.43 M59.29 M
Interest Expense3.02 M3.8 M6.62 M15.96 M16.44 M17.74 M
Net Income(127.79 M)(106.29 M)(121.69 M)(127.29 M)(215.31 M)(220.98 M)
Net Income Common Stock(127.79 M)(106.29 M)(121.69 M)(127.29 M)(215.31 M)(220.98 M)
Net Income Common Stock USD(127.79 M)(106.29 M)(121.69 M)(127.29 M)(215.31 M)(220.98 M)
Operating Expenses126.76 M120.42 M125.73 M149.77 M256.74 M277.01 M
Operating Income(113.4 M)(88.92 M)(98.87 M)(93.94 M)(186.31 M)(191.22 M)
Revenues13.37 M31.5 M26.87 M55.83 M70.43 M59.29 M
Revenues USD13.37 M31.5 M26.87 M55.83 M70.43 M59.29 M
Research and Development Expense90.3 M89.14 M86.12 M96.95 M159.94 M172.56 M
Selling General and Administrative Expense36.47 M31.28 M39.61 M52.82 M96.8 M104.45 M
Weighted Average Shares49.4 M54.42 M57.58 M64.52 M76.89 M65.44 M
Weighted Average Shares Diluted49.4 M54.42 M57.58 M64.52 M76.89 M65.58 M

Cytokinetics Investors Sentiment

The influence of Cytokinetics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cytokinetics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Cytokinetics' public news can be used to forecast risks associated with investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Cytokinetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cytokinetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cytokinetics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Cytokinetics.

Cytokinetics Implied Volatility

    
  81.55  
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytokinetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytokinetics' short interest history, or implied volatility extrapolated from Cytokinetics options trading.

Current Sentiment - CYTK

Cytokinetics Investor Sentiment

Most of Macroaxis users are currently bullish on Cytokinetics. What is your opinion about investing in Cytokinetics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Continue to Trending Equities. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.8 B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.